Revised SPC: Neurontin (gabapentin) Tablets

SPC warns of risk of fatal respiratory depression with concomitant administration with opioid-containing drugs and other CNS depressants. Patients who require concomitant treatment should be carefully observed for signs, such as somnolence, sedation, and respiratory depression.

Source:

electronic Medicines compendium